FNDC3A

Chr 13

fibronectin type III domain containing 3A

Also known as: FNDC3, HUGO, bA203I16.1, bA203I16.5

Enables RNA binding activity. Predicted to be involved in spermatid development. Predicted to act upstream of or within Sertoli cell development; cell-cell adhesion; and fertilization. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
5
Pubs (1 yr)
P/LP submissions
P/LP missense
0.22
LOEUF· LoF intol.
LOF
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.22LOEUF
pLI 1.000
Z-score 6.58
OE 0.12 (0.070.22)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.53Z-score
OE missense 0.83 (0.770.89)
527 obs / 635.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.12 (0.070.22)
00.351.4
Missense OE?0.83 (0.770.89)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 8 / 65.4Missense obs/exp: 527 / 635.5Syn Z: 0.47

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FNDC3A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →